Pfizer Inc. (PFE)
NYSE: PFE
· Real-Time Price · USD
24.27
0.08 (0.33%)
At close: Jun 30, 2025, 3:59 PM
24.22
-0.19%
After-hours: Jun 30, 2025, 05:54 PM EDT
0.33% (1D)
Bid | 24.21 |
Market Cap | 137.96B |
Revenue (ttm) | 62.46B |
Net Income (ttm) | 7.87B |
EPS (ttm) | 1.38 |
PE Ratio (ttm) | 17.58 |
Forward PE | 7.86 |
Analyst | Hold |
Ask | 24.24 |
Volume | 32,611,989 |
Avg. Volume (20D) | 47,372,403 |
Open | 24.21 |
Previous Close | 24.19 |
Day's Range | 24.12 - 24.38 |
52-Week Range | 20.92 - 31.54 |
Beta | 0.49 |
Analyst Forecast
According to 0 analyst ratings, the average rating for PFE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Pfizer Inc. is scheduled to release its earnings on Aug 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+2.26%
Shares of vaccine stocks are trading higher follow...
Unlock content with
Pro Subscription
1 month ago
+2.26%
Pfizer shares are trading higher after the company announced it secured the global rights to China's 3SBio cancer drug in a $6 billion deal.